Market revenue in 2023 | USD 731.4 million |
Market revenue in 2030 | USD 1,349.9 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Mammals |
Fastest growing segment | Reptiles |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Mammals, Birds, Fishes, Reptiles, Amphibians |
Key market players worldwide | Boehringer Ingelheim, NexgenRx Inc, Virbac SA, Wedgewood Institutional, Danone SA, Genie Energy Ltd Class B, PetMed Express Inc, Taylor Devices Inc, DONGBANG TRANSPORT & LOGISTICS CO LTD, Pneu-Dart |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wildlife health market will help companies and investors design strategic landscapes.
Mammals was the largest segment with a revenue share of 46.02% in 2023. Horizon Databook has segmented the North America wildlife health market based on mammals, birds, fishes, reptiles, amphibians covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America wildlife health market , including forecasts for subscribers. This continent databook contains high-level insights into North America wildlife health market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account